Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
28. September 2023 11:15 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic to Participate in Chardan’s Genetic Medicines Conference
21. September 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100
19. September 2023 11:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Dr. Gary Donovitz, Founder of BioTE, Provides Public Apology to Dr. Terri DeNeui and Dan DeNeui of EVEXIAS Health Solutions
24. Mai 2022 10:00 ET
|
EVEXIAS Health Solutions
SOUTHLAKE, Texas, May 24, 2022 (GLOBE NEWSWIRE) -- People who pursue hormone replacement therapy are seeking a happier, healthier life. The goal of practitioners who offer hormone pellet therapy is...